1. Home
  2. XLO vs XTNT Comparison

XLO vs XTNT Comparison

Compare XLO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.17

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.31

Market Cap

61.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
XTNT
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
61.7M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
XLO
XTNT
Price
$9.17
$0.31
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$1.00
AVG Volume (30 Days)
23.3K
127.5K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.00
EPS
N/A
N/A
Revenue
$43,766,000.00
$53,337,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
$9.30
P/E Ratio
N/A
N/A
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$0.27
52 Week High
$9.89
$0.95

Technical Indicators

Market Signals
Indicator
XLO
XTNT
Relative Strength Index (RSI) 55.69 21.45
Support Level $7.47 N/A
Resistance Level $9.22 $0.47
Average True Range (ATR) 0.38 0.03
MACD -0.00 -0.02
Stochastic Oscillator 54.04 20.02

Price Performance

Historical Comparison
XLO
XTNT

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: